NervGen Pharma Corp. (TSXV:NGEN)
Canada
· Delayed Price · Currency is CAD 3.000
+0.130 (4.53%)
Apr 1, 2025, 3:59 PM EST
NervGen Pharma Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Cash & Equivalents | 21.01 | 11.66 | 22.45 | 16.93 | 5.6 | 4.11 | Upgrade
|
| Cash & Short-Term Investments | 21.01 | 11.66 | 22.45 | 16.93 | 5.6 | 4.11 | Upgrade
|
| Cash Growth | 42.09% | -48.07% | 32.62% | 202.38% | 36.34% | 65.95% | Upgrade
|
| Other Receivables | 0.01 | 0.25 | 0.03 | 0.06 | 0.06 | 0.12 | Upgrade
|
| Receivables | 0.01 | 0.25 | 0.03 | 0.06 | 0.06 | 0.12 | Upgrade
|
| Prepaid Expenses | 0.17 | 0.11 | 0.08 | 0.07 | 0.05 | 0.04 | Upgrade
|
| Other Current Assets | 0.76 | 0.5 | 0.59 | 0.36 | 0.49 | 1.98 | Upgrade
|
| Total Current Assets | 21.94 | 12.52 | 23.15 | 17.42 | 6.2 | 6.26 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.2 | 0.3 | 0 | 0 | - | Upgrade
|
| Other Intangible Assets | 0.48 | 0.52 | 0.43 | 0.47 | 0.47 | 0.51 | Upgrade
|
| Total Assets | 22.46 | 13.24 | 23.88 | 17.9 | 6.68 | 6.77 | Upgrade
|
| Accounts Payable | 0.46 | 0.55 | 2 | 0.35 | 0.17 | 0.5 | Upgrade
|
| Accrued Expenses | 2.93 | 2.77 | 1.4 | 0.73 | 0.58 | 0.42 | Upgrade
|
| Current Portion of Leases | 0.1 | 0.09 | 0.09 | - | - | - | Upgrade
|
| Other Current Liabilities | 9.76 | 11.73 | 6.73 | - | - | - | Upgrade
|
| Total Current Liabilities | 13.25 | 15.14 | 10.22 | 1.08 | 0.76 | 0.92 | Upgrade
|
| Long-Term Leases | 0.03 | 0.11 | 0.2 | - | - | - | Upgrade
|
| Total Liabilities | 13.28 | 15.25 | 10.41 | 1.08 | 0.76 | 0.92 | Upgrade
|
| Common Stock | 80.5 | 58.93 | 57.41 | 42.4 | 22.95 | 15.29 | Upgrade
|
| Retained Earnings | -93.55 | -78.15 | -55.77 | -35.05 | -22.32 | -11.14 | Upgrade
|
| Comprehensive Income & Other | 22.23 | 17.21 | 11.82 | 9.46 | 5.3 | 1.68 | Upgrade
|
| Shareholders' Equity | 9.18 | -2.01 | 13.46 | 16.82 | 5.92 | 5.84 | Upgrade
|
| Total Liabilities & Equity | 22.46 | 13.24 | 23.88 | 17.9 | 6.68 | 6.77 | Upgrade
|
| Total Debt | 0.13 | 0.2 | 0.28 | - | - | - | Upgrade
|
| Net Cash (Debt) | 20.88 | 11.46 | 22.17 | 16.93 | 5.6 | 4.11 | Upgrade
|
| Net Cash Growth | 43.34% | -48.29% | 30.95% | 202.38% | 36.34% | 65.95% | Upgrade
|
| Net Cash Per Share | 0.32 | 0.19 | 0.42 | 0.43 | 0.17 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 70.31 | 69.93 | 59.13 | 46.23 | 35.86 | 29.47 | Upgrade
|
| Total Common Shares Outstanding | 70.19 | 59.61 | 58.78 | 46.19 | 35.17 | 29.35 | Upgrade
|
| Working Capital | 8.7 | -2.62 | 12.93 | 16.34 | 5.45 | 5.33 | Upgrade
|
| Book Value Per Share | 0.13 | -0.03 | 0.23 | 0.36 | 0.17 | 0.20 | Upgrade
|
| Tangible Book Value | 8.7 | -2.53 | 13.03 | 16.35 | 5.45 | 5.33 | Upgrade
|
| Tangible Book Value Per Share | 0.12 | -0.04 | 0.22 | 0.35 | 0.15 | 0.18 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.